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Volume 49, Number 6 Mackey 1385ment success. The rigorous patient de-identification pro-
cess employed by the State Inpatient Databases to protect
patient confidentiality precludes the analysis of longitudinal
clinical data. Therefore, it was impossible to evaluate other
equally important outcomes, such as long-term morbidity
and mortality or restenosis.
CONCLUSION
Despite a paucity of evidence in support of performing
CAS in asymptomatic patients and current CMS guidelines
reimbursing CAS for only high-risk symptomatic patients,
both VS and non-VS are treating primarily asymptomatic
patients. Perioperative rates of stroke and death are equiv-
alent between VS, IC, and IR. Regional variation is sub-
stantial, and despite similar outcomes, fewer than 50% of
CAS procedures are performed by VS.
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This study, based on an administrative database of 4000
carotid stent procedures, has three major findings: (1) 91%
of carotid stents are performed in asymptomatic patients, (2)carotid stents (46% by vascular surgeons in New York and only
19% by vascular surgeons in Florida), and (3) early outcomes
across the three specialties performing carotid stenting are
equivalent.
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June 20091386 MackeyThe first finding defies rational analysis. It is astonishing that
fully 91% of the patients undergoing stenting in New York and
Florida in 2005 and 2006 were asymptomatic. There are no level I
data supporting carotid stenting as superior to medical manage-
ment in asymptomatic patients, and the Centers for Medicare and
Medicaid Services recently reaffirmed its policy of nonpayment for
carotid stenting in asymptomatic patients. So what was the ratio-
nale for stenting these patients, and how were those performing
the stents reimbursed?
The second finding of marked regional variation in provider
type may reflect dissimilar referral patterns. Alternatively, such
variation might reflect variability in the acceptance of carotid
stenting among different provider types in New York and Florida.
Regional variation in provider acceptance of carotid stenting likely
stems from the absence of high-level data defining the precise role
of carotid stenting and from the nonevidence-based and nonclini-
cal drivers of its use.
The third major finding is problematic. The statistically equiv-tional cardiologists, and 2.0% for interventional radiologists are
lower than those seen in prospectively gathered data sets. The
authors attribute these unrealistically low stroke rates to “coding
errors” and minimize their significance because they should affect
all provider types equally and, therefore, not affect the outcome
comparisons. Still, the publication of these stroke rates may result
in the misinterpretation that carotid stenting is very safe as per-
formed across the full spectrum of practice settings. Of course, the
major flaw in these outcome data is their source. Administrative
databases paint with very broad brushstrokes and do not permit an
accurate determination of procedure indications, risk stratification,
nonlethal complications, and longitudinal follow-up.
The real value of this study is its reflection of the current chaos
engulfing carotid disease management. The unexplained regional
variation in practice patterns results from clinical decisions based
on locally prevailing opinion, individual whim, and financial mo-
tives. In the absence of widely accepted evidence-based practicealent stroke rates of 1.3% for vascular surgeons, 1.1% for interven- standards, such clinical decisions fill the void.
